Format
Sort by

Send to

Choose Destination

Search results

Items: 7

1.

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.

Perez T, Burgel PR, Paillasseur JL, Caillaud D, Deslée G, Chanez P, Roche N; INITIATIVES BPCO Scientific Committee.

Int J Chron Obstruct Pulmon Dis. 2015 Aug 18;10:1663-72. doi: 10.2147/COPD.S82408. eCollection 2015.

2.

Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment.

Roche N, Jebrak G, Caillaud D, Deslée G, Brinchault G, Chanez P, Court-Fortune I, Escamilla R, Nesme-Meyer P, Pinet C, Carré P, Paillasseur JL, Perez T, Burgel PR; Initiatives BPCO scientific committee.

Eur Respir J. 2015 Jan;45(1):260-2. doi: 10.1183/09031936.00131614. Epub 2014 Oct 30. No abstract available.

3.

Impact of gender on COPD expression in a real-life cohort.

Roche N, Deslée G, Caillaud D, Brinchault G, Court-Fortune I, Nesme-Meyer P, Surpas P, Escamilla R, Perez T, Chanez P, Pinet C, Jebrak G, Paillasseur JL, Burgel PR; INITIATIVES BPCO Scientific Committee.

Respir Res. 2014 Feb 17;15:20. doi: 10.1186/1465-9921-15-20.

4.

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?

Burgel PR, Deslée G, Jebrak G, Brinchault G, Caillaud D, Chanez P, Court-Fortune I, Escamilla R, Nesme-Meyer P, Paillasseur JL, Perez T, Roche N; Initiatives BPCO scientific committee.

Eur Respir J. 2014 Apr;43(4):1201-3. doi: 10.1183/09031936.00162313. Epub 2013 Oct 31. No abstract available.

5.

Impact of comorbidities on COPD-specific health-related quality of life.

Burgel PR, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, Pinet C, Jebrak G, Brinchault G, Court-Fortune I, Paillasseur JL, Roche N; INITIATIVES BPCO Scientific Committee.

Respir Med. 2013 Feb;107(2):233-41. doi: 10.1016/j.rmed.2012.10.002. Epub 2012 Oct 23.

6.

Clinical COPD phenotypes identified by cluster analysis: validation with mortality.

Burgel PR, Roche N, Paillasseur JL, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Caillaud D; INITIATIVES BPCO Scientific Committee.

Eur Respir J. 2012 Aug;40(2):495-6. No abstract available.

7.

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.

Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Roche N; Initiatives BPCO Scientific Committee.

Eur Respir J. 2010 Sep;36(3):531-9. doi: 10.1183/09031936.00175109. Epub 2010 Jan 14.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk